Study guide
11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD
NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacist Licensure & Reciprocity
1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement
2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios
2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles
3 Chapter 3: Prescriptive Authority & Practitioner Categories
3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members
4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)
4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR
5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements
5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing
6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling
6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)
7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose
7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping
8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety
9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs
10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution
10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution
11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>
11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment
12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy
12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols
11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD
Key Takeaways Explain This Topic AI
USP <797> sets mandatory standards for Compounded Sterile Preparations (CSPs), establishing strict ISO air cleanliness classifications for primary and secondary engineering controls.
ISO Class 5 environment (≤ 3,520 particles/m³) is required inside Primary Engineering Controls (PECs) such as laminar airflow workbenches (LAFW) and compounding aseptic isolators (CAI).
Secondary Engineering Controls (SECs) require an ISO Class 7 Buffer Room (minimum 30 ACPH) and an ISO Class 8 Ante-Room (minimum 20 ACPH) with positive pressure differential.
Category 1 CSPs are prepared in an unclassified Segregated Compounding Area (SCA) and carry limited BUDs of ≤ 12 hours at room temperature or ≤ 24 hours refrigerated.
Category 2 CSPs are compounded in a full cleanroom suite, with BUDs assigned based on aseptic processing versus terminal sterilization, starting component sterility, and storage temperature.
Last updated: July 2026
11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD
MPJE Core Concept: USP General Chapter <797> regulates Compounded Sterile Preparations (CSPs) to prevent severe patient harm resulting from microbial contamination, pyrogenicity, or strength errors. MPJE questions focus heavily on ISO air classifications , cleanroom pressure differentials , Category 1 vs. Category 2 CSPs , and environmental sampling protocols .
ISO Air Cleanliness Classifications (ISO 14644-1 Standards)
Air quality in sterile compounding environments is categorized by International Organization for Standardization (ISO) standards based on maximum allowable airborne particle counts per cubic meter ( particles / m 3 \text{particles}/\text{m}^3 particles / m 3 ) of size 0.5 μ m 0.5\ \mu\text{m} 0.5 μ m and larger :
ISO Class 5: Maximum 3,520 particles/m³ . Mandatory for the direct compounding area inside Primary Engineering Controls (PECs) (e.g., Laminar Airflow Workbenches / LAFW, Class II Biological Safety Cabinets / BSC, Compounding Aseptic Isolators / CAI).
ISO Class 7: Maximum 352,000 particles/m³ . Mandatory for Secondary Engineering Control (SEC) Buffer Rooms .
ISO Class 8: Maximum 3,520,000 particles/m³ . Mandatory for Ante-Rooms entering positive-pressure non-hazardous buffer areas.
Cleanroom Architecture & Pressure Differentials
A compliant sterile compounding cleanroom suite consists of physically separated zones engineered to maintain positive airflow from cleanest areas outward:
1. Ante-Room (ISO Class 8 or ISO Class 7)
The ante-room is the transitional space where personnel perform hand hygiene, garbing, staging of supplies, and unpacking of outer shipping cartons. Sinks must be located in the ante-room.
ISO Class 8 requirement if entering a positive-pressure non-hazardous buffer room.
ISO Class 7 requirement if entering a negative-pressure hazardous buffer room.
Air Changes Per Hour (ACPH): Minimum 20 ACPH supplied by HEPA filters.
2. Buffer Room (ISO Class 7)
The buffer room houses the Primary Engineering Control (PEC) where sterile compounding occurs.
ISO Class 7 air quality required under dynamic operating conditions.
Air Changes Per Hour (ACPH): Minimum 30 ACPH of HEPA-filtered air.
Strict Prohibitions: Sinks, floor drains, and non-essential furniture are strictly prohibited in the buffer room.
3. Positive Pressure Differentials
In non-hazardous compounding, the buffer room must maintain positive pressure relative to the ante-room, and the ante-room must maintain positive pressure relative to unclassified corridors:
Minimum Pressure Differential: 0.02 to 0.05 inches of water column (5 to 12.5 Pascals) between adjacent rooms to ensure clean air cascades outward, preventing unsterilized air entry.
CSP Categorization & Beyond-Use Dating (USP <797> 2023 Revision)
USP <797> categorizes Compounded Sterile Preparations (CSPs) into Category 1 , Category 2 , and Category 3 based on the environment in which they are prepared and the probability of microbial growth:
Category 1 CSPs
Environment: Compounded inside an ISO Class 5 PEC located in an unclassified Segregated Compounding Area (SCA) (not inside a full cleanroom suite).
Maximum Assigned BUDs:
- Controlled Room Temperature (20°C to 25°C): 12 hours
- Refrigerated (2°C to 8°C): 24 hours
- Category 2 CSPs
Environment: Compounded in an ISO Class 5 PEC located within a compliant ISO Class 7 Buffer Room with an ISO Class 8 Ante-Room cleanroom suite.
BUD Factors: BUD depends on aseptic processing vs. terminal sterilization, component sterility (sterile vs. nonsterile starting APIs), sterility testing, and storage conditions.
Category 2 BUD Limits (Without USP <71> Sterility Testing Passed):
Preparation Method Starting Components Controlled Room Temp (20°-25°C) Refrigerated (2°-8°C) Frozen (-25° to -10°C)
- Aseptic Processing All Sterile Components 4 days 10 days 45 days
- Aseptic Processing 1+ Nonsterile Component 1 day 4 days 45 days
- Terminal Sterilization Sterile or Nonsterile 14 days 28 days 45 days
Category 2 BUD Limits (WITH USP <71> Sterility Testing Passed):
Aseptically Processed: 30 days Room Temp / 45 days Refrigerated / 60 days Frozen.
Terminally Sterilized: 45 days Room Temp / 60 days Refrigerated / 90 days Frozen.
Category 3 CSPs
Environment: Prepared in cleanroom suites meeting extended specifications with continuous environmental monitoring, mandatory sterility (USP <71>) and endotoxin (USP <85>) testing, container-closure integrity validation, and specialized garbing/sanitization protocols. BUDs can extend up to 60 days Room Temp, 90 days Refrigerated, and 120 days Frozen (up to 180 days for terminally sterilized preparations).
Personnel Competency & Environmental Monitoring
Sterile compounding personnel must pass rigorous initial and ongoing evaluations:
Glove Fingertip and Thumb Sampling: Initial qualification requires 3 consecutive zero-CFU (Colony Forming Unit) samples from both hands immediately after garbing. Ongoing re-qualification is required annually for Category 1/2 (or semi-annually for Category 3).
Media-Fill Testing: Simulates aseptic compounding using soybean-casein digest medium (tryptic soy broth). Must be performed initially and re-tested at least every 6 months for Category 2/3 (or 12 months for Category 1).
Environmental Air & Surface Monitoring:
Viable Air Sampling: Performed at least every 6 months .
Non-Viable Particle Monitoring: Performed at least every 6 months .
Surface Sampling: Conducted periodically/monthly at the end of compounding shifts (Action levels: > 3 CFU in ISO 5, > 5 CFU in ISO 7, > 100 CFU in ISO 8).